Category: Business contacts
-
Coronavirus Patents: China Files for Remdesivir Patent, but Gilead Sciences Will Still Come Out a Winner
On February 4, the Wuhan Institute of Virology announced that it had applied for a Chinese patent on Gilead’s Remdesivir…
-
Medical supply chains are fragile in the best of times and COVID-19 will test their strength
The COVID-19 pandemic has brought medical supply chains into the spotlight. <ClickHere>
-
Will governments override patent rights in the race to find a cure for COVID-19?
The outbreak of COVID-19 coronavirus has prompted a global race to find a vaccine to fight the disease. <ClickHere>
-
“Playing Both Sides?” Branded Sales, Generic Sales and Patent Policy
In this article, we explore a phenomenon we call “playing both sides”: companies that participate in pharmaceutical markets as both…
-
Leveraging Crowdsourcing to Facilitate the Discovery of New Medicines
Gloomy predictions about the future of pharma have forced the industry to investigate alternative models of drug discovery. Public-private partnerships…
-
Drug Patent Expirations and the “Patent Cliff”
Beginning in 2010, the pharmaceutical industry faced one of the biggest waves of drug patent expirations in history, a phenomenon…
-
The Structural Changes in the Global Pharmaceutical Marketplace and Their Possible Implications for Intellectual Property
A number of changes have taken place in the global pharmaceutical marketplace over the last decade that are putting pressure…
-
EU Auto Stats
ACEA compiles registration figures for passenger cars and commercial vehicles, each released once a month
-
who’s spending the most on artificial intelligence in the car industry?
Toyota has put $1 billion (£663 million) aside for AI
-
Monetizing car data
A report on new service business opportunities to create new customer benefits